Treatment of asthma with lipid extract of New Zealand green-lipped mussel: A randomised clinical trial

European Respiratory Journal

Volumn 20, Issue 3, 2002, Pages 596-600

  Emelyanov, A ^a   Fedoseev, G ^a   Krasnoschekova, O ^a   Abulimity, A ^a   Trendeleva, T ^a   Barnes, P J ^a  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

A thma; Green lipped mussel; Lipid extract; Treatment

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; HYDROGEN PEROXIDE; ICOSANOID; ICOSAPENTAENOIC ACID; LEUKOTRIENE; LIPID; LYPRINOL; OLIVE OIL; OMEGA 3 FATTY ACID; PLACEBO; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; SALBUTAMOL; STEROID; TERBUTALINE;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFECT; ENZYME INHIBITION; EXHALATION; FEMALE; HUMAN; INFLAMMATORY DISEASE; MALE; MUSSEL; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SYMPTOM; WHEEZING;

ADOLESCENT; ADULT; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BIVALVIA; BREATH TESTS; DOUBLE-BLIND METHOD; FORCED EXPIRATORY VOLUME; HUMANS; HYDROGEN PEROXIDE; LIPIDS; LIPOXYGENASE INHIBITORS; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; TISSUE EXTRACTS;

EID: 0036738264     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.02632001     Document Type: Article

References (26)

1. Anti-inflammatory activity of a lipid fraction (Lyprinol) from the NZ green-lipped mussel
2. Gastroprotective and anti-inflammatory properties of green-lipped mussel (Perna canaliculus) preparation
3. Anti-inflammatory effects of a stabilized lipid extract of Perna Canaliculus (Lyprinol®)
4. Marine lipids: Overview "news insights and lipid composition of Lyprinol"
5. The treatment of arthritis with lipid extract of Perna canaliculus: A randomized trial
6. Perna canaliculus in the treatment of arthritis
7. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
8. Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients
9. 2 and 3,3′,5,5′-tetramethybenzidine
10. The effect of dietary supplementation with ω-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells
11. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974
12. The relationship of dietary fish oil intake to level of pulmonary function in the first National Health and Nutritional Survey
13. Factors associated with bronchial hyperresponsiveness in Australian adults and children
14. An epidemiological study of the preventive effect of dietary fish on bronchial asthma
15. Dietary supplementation with fish oil rich in ω-3 polyunsaturated fatty acids in children with bronchial asthma
16. Leukotrienes: Potent mediators of airway constriction
17. 4 in allergen-induced increases in airway smooth muscle in rat
18. 4, increase the release of mucus from human airway in vitro
19. Leukotrienes promote plasma leakage and leukocyte adhesion in post-capillary venules: In vitro effects with relevance to the acute inflammatory response
20. 4 cause granulocyte infiltration into asthmatic airway
21. Antioxidant enzymes and their implications in pathophysiologic processes
22. Exhaled markers of pulmonary diseases
23. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients
24. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma
25. Hydrogen peroxide in expired air condensate correlates positively with early steps of peripheral neutrophil activation in asthmatic patients